Skip to main content

Table 1 Selected CTL peptide epitopes and their scores

From: Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma

Database

Allele

Sequence

Start–End

Length (aa)c

MHC prediction

TAP prediction score

Combined prediction score

% Rank

Affinity (1-log50k)

HLAa

MHCb

HLA

MHC

HLA

MHC

HLA

MHC

HLA

MHC

HLA

MHC

NetCTLpan

HLA-A*02:01

H-2-Db

H-2-kb

YMISYAGMV (V1)

189–198

9

0.861

 

0.539

 

0.95325

 

0.4

   

HLA-A*02:01

H-2-Db

H-2-kb

YTVILTNPI (V2)

396–404

9

0.394

 

0.712

 

0.6235

 

3

   

HLA-A*02:01

H-2-Db

H-2-kb

IQAANVSAL (V3)

519–527

9

0.441

 

1.117

 

0.58019

 

4

   

IEDB

HLA-A*02:01

H-2-Db

H-2-kb

YMISYAGMV (V1)

189–198

9

− 2.16

− 1.98

0.24

0.23

− 0.96

− 0.86

    

HLA-A*02:01

H-2-Db

H-2-kb

YTVILTNPI (V2)

396–404

9

− 2.65

− 2.48

0.31

0.31

− 1.57

− 1.26

    

HLA-A*02:01

H-2-Db

/H-2-kb

IQAANVSAL (V3)

519–527

9

− 2.6

− 2.04

0.49

0.49

− 0.85

− 0.29

    

NetMHC 4.0

HLA-A*02:01

H-2-Db

H-2-kb

YMISYAGMV (V1)

189–198

9

  

`

   

0.5

2

0.828

0.483

HLA-A*02:01

H-2-Db

H-2-kb

YTVILTNPI (V2)

396–404

9

      

3

0.1

0.435

0.515

HLA-A*02:01

H-2-Db

H-2-kb

IQAANVSAL (V3)

519–527

9

      

3.5

0.12

0.4

0.499

PickPocket 1.1

HLA-A*02:01

H-2-Db

H-2-kb

YMISYAGMV (V1)

189–198

9

        

0.796

0.413

HLA-A*02:01

H-2-Db

H-2-kb

YTVILTNPI (V2)

396–404

9

        

0.434

0.407

HLA-A*02:01

H-2-Db

H-2-kb

IQAANVSAL (V3)

519–527

9

        

0.492

0.466

  1. aHuman leukocyte antigen
  2. bMajor histocompatibility complex
  3. CAmino acid